Authors: Chiara, S Lionetto, R Vincenti, M Bruzzone, M Nobile, MT Gadducci, A Carnino, F Rosso, R Conte, P

Citation: S. Chiara et al., Advanced ovarian cancer in the elderly: results of consecutive trials withcisplatin-based chemotherapy, CR R ONC H, 37(1), 2001, pp. 27-34

Authors: Boccardo, F Miglietta, L Bruzzone, M Rubagotti, A Locatelli, MC Ragni, N

Citation: F. Boccardo et al., Paclitaxel plus organoplatins: Still the gold standard in advanced ovariancancer?, ANN ONCOL, 12(7), 2001, pp. 1023-1024

Authors: Gadducci, A Carnino, F Chiara, S Brunetti, I Tanganelli, L Romanini, A Bruzzone, M Conte, PF

Citation: A. Gadducci et al., Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Noud-Ovest, GYNECOL ONC, 76(2), 2000, pp. 157-162

Authors: Flatau, G Landraud, L Boquet, P Bruzzone, M Munro, P

Citation: G. Flatau et al., Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain, BIOC BIOP R, 267(2), 2000, pp. 588-592

Authors: Gaita, F Bocchiardo, M Porciani, MC Vivalda, L Colella, A Di Donno, P Caponi, D Bruzzone, M Padeletti, L

Citation: F. Gaita et al., Should stimulation therapy for congestive heart failure be combined with defibrillation backup?, AM J CARD, 86(9A), 2000, pp. 165K-168K